INT Medical converts 71.79 million domestic shares into H shares, expanding HKEX-listed share base to 211.20 million

Bulletin Express07-02

Shanghai INT Medical Instruments Co., Ltd. (INT Medical) disclosed in its Monthly Return for Equity Issuer that, on 3 June 2026, 71.79 million domestic shares were converted into an equal number of H shares.

Following the conversion, the company’s entire issued share capital now consists of 211.20 million ordinary H shares with a par value of RMB1.00 each, all listed on the Hong Kong Stock Exchange. Compared with the end of May, the H-share count increased by 51.53%, while the domestic-share class was fully cancelled.

INT Medical confirmed that the public float meets the Main Board’s 25% minimum requirement. No share options, warrants, convertibles, treasury shares or other equity instruments were outstanding or transacted during the month.

The filing was signed by Chairman and Executive Director Liang Dongke on 2 July 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment